These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2054404)

  • 1. A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma.
    Titus-Ernstoff L; Ernstoff MS; Duray PH; Barnhill RL; Holubkov R; Kirkwood JM
    Epidemiology; 1991 May; 2(3):210-4. PubMed ID: 2054404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunlight and dysplastic nevus risk. Results of a clinic-based case-control study.
    Weinstock MA; Stryker WS; Stampfer MJ; Lew RA; Willett WC; Sober AJ
    Cancer; 1991 Mar; 67(6):1701-6. PubMed ID: 2001561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic (atypical) nevi: significance and management.
    Lober CW
    South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
    Roush GC; Barnhill RL
    Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.
    Roush GC; Nordlund JJ; Forget B; Gruber SB; Kirkwood JM
    Prev Med; 1988 May; 17(3):273-9. PubMed ID: 3405984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous dysplastic naevi: risk factor for uveal melanoma.
    Hammer H; Tóth-Molńar E; Oláh J; Dobozy A
    Lancet; 1995 Jul; 346(8969):255-6. PubMed ID: 7616832
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocytic naevi in sun-exposed and protected skin in melanoma patients and controls.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):512-7. PubMed ID: 1685834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
    Stierner U; Augustsson A; Rosdahl I; Suurküla M
    Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer.
    Kennedy C; Bajdik CD; Willemze R; De Gruijl FR; Bouwes Bavinck JN;
    J Invest Dermatol; 2003 Jun; 120(6):1087-93. PubMed ID: 12787139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic naevi, melanoma and sun exposure.
    Augustsson A
    Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant melanoma--a warning. How to reduce mortality?].
    Volden G; Rajka G; Thune P; Falk ES; Krogh HK
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1202-5. PubMed ID: 2333644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure.
    White E; Kirkpatrick CS; Lee JA
    Am J Epidemiol; 1994 May; 139(9):857-68. PubMed ID: 8166136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
    Landi MT; Baccarelli A; Tarone RE; Pesatori A; Tucker MA; Hedayati M; Grossman L
    J Natl Cancer Inst; 2002 Jan; 94(2):94-101. PubMed ID: 11792747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
    Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
    JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An impact of hormones on nevi and melanoma.
    Lens M; Rosdahl I
    J Am Acad Dermatol; 2008 Jun; 58(6):1083-4; author reply 1084-5. PubMed ID: 18485992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.